Skip to content
ReframedNewsLeft · Right · Centered
Quick ReadArchiveAboutSign in
Briefing stories›Science & Climate

Trial reports tumor shrinkage and some complete responses from amivantamab in treatment-resistant head and neck cancer

Story date · Saturday, May 30, 2026Science & ClimateWell-covered

The facts

  • The trial tested amivantamab in patients with recurrent and/or metastatic head and neck cancer whose disease had spread or returned after other treatments stopped working.
  • The study was international, spanning 11 countries.
  • Reports on the trial say tumors shrank in 42% of patients, or in more than a third of participants.
  • In 15 patients, doctors reported complete disappearance of tumors after treatment with amivantamab.
  • The trial included 102 patients.
  • The patients in the trial had disease that had become resistant to both chemotherapy and immunotherapy, a group described by researchers as having limited remaining treatment options.
  • Amivantamab was given as an injection rather than the intravenous-drip format used for many cancer medicines.
  • The reports describe these findings as coming from a trial, meaning further study is still needed before the treatment's role in routine care is settled.

Context

Who was included in this trial?

The trial involved 102 patients with recurrent or metastatic head and neck cancer whose disease had spread or returned and was no longer responding to standard treatment, including chemotherapy and immunotherapy Independent,il Giornale.it,Metro,Irish Times.

What results were reported?

Across reports on the study, amivantamab was said to shrink tumors in 42% of patients, and doctors reported complete tumor disappearance in 15 patients Mirror,ITV Hub,Metro,Irish Times.

Why are these findings getting attention?

The results concern a patient group whose cancer had already stopped responding to existing treatments, so any evidence of tumor shrinkage or complete response could point to a new option where few remain; however, the evidence cited here comes from a clinical trial, so more research is needed Independent,Metro,Irish Times.

Common ground, and where they split

Common ground
Patients whose head and neck cancer had already resisted chemotherapy and immunotherapy have few remaining options, so reports of tumors shrinking in 42% of cases and disappearing entirely in 15 are meaningful even though the findings are still preliminary.
Where Left and Right split
Less a disagreement than a question of emphasis: the significance of a rare response in patients with limited options, versus the discipline of treating an encouraging trial signal as unproven until routine use is settled.

How left and right read it

Left says

What stands out here is that the trial focused on people with recurrent or metastatic head and neck cancer whose disease had already become resistant to both chemotherapy and immunotherapy, leaving them with limited remaining options. In that context, reports that tumors shrank in 42% of patients and disappeared completely in 15 cases are striking, even as the findings are still early and further study is needed before routine use is settled.

Right says

What stands out here is a concrete result in a hard case: among 102 patients whose cancer had already resisted both chemotherapy and immunotherapy, reports say tumors shrank in 42% of patients and disappeared entirely in 15 cases. Just as important, this remains a trial, so the encouraging signal should be taken seriously without pretending the treatment’s place in routine care is already settled.

See this differently than someone you know would?

The receipts — 54 sources

Other coverage (54)

MetroCancer jab could eradicate entire tumours following 'unprece...
Novinite.comNew Cancer Jab Eliminates Tumors in Patients as Trial Delive...
MM NEWSNew cancer vaccine eliminates tumors in clinical trial
GazzettinoTumori, un vaccino può eliminarli: il nuovo studio dai risul...
Daily SabahCancer trial shows promising results for treatment-resistant...
il Giornale.itVaccino può eliminare il cancro: la speranza da un nuovo stu...
En Son HaberMeme kanserinde kemoterapiyi belirleyen test geliştirildi - ...
TürkiyeMilyonlarca hastaya umut! Yeni bir DNA testi, gereksiz kemot...
LBCCancer jab shown to eradicate whole tumours in patients in p...
ITV HubCancer jab destroys whole tumours in treatment-resistant cas...
YahooCancer jab destroys whole tumours in treatment-resistant cas...
MirrorCancer jab 'eradicates whole tumours' in 15 patients - 7 key...
https://www.pharmastar.itTumore del polmone non a piccole cellule con alterazioni del...
SabahKemoterapide yeni dönem
Malay MailDoctors report breakthrough as cancer jab reportedly eradica...
Yahoo NewsDoctors report breakthrough as cancer jab reportedly eradica...
The Business StandardCancer injection shows promise in advanced head and neck can...
HABER ANKARAMeme kanserinde kemoterapiden fayda görmeyecek hastalar tesp...
Countryman'Unprecedented' cancer jab can destroy whole tumours
The IndependentDoctors hail cancer injection that can destroy entire tumors
bursahakimiyet.com.trMilyonlarca meme kanseri hastası için umut verici gelişme! B...
Adnkronos"Un vaccino può eliminare il tumore", la speranza dal nuovo ...
OglioPoNews"Un vaccino può eliminare il tumore", la speranza dal nuovo ...
Internewscast JournalGroundbreaking Cancer Treatment Restores Patient's Ability t...
Mail OnlineCancer jabs destroy whole tumours in treatment-resistant cas...
CumhuriyetGeliştirilen DNA testi, milyonlarca meme kanseri hastasını k...
The Irish TimesCancer jab can eradicate entire tumours in patients, trial s...
MirrorCancer jabs destroy whole tumours in treatment-resistant cas...
Haber AktüelProsigna Testi, Meme Kanserinde Gereksiz Kemoterapiyi Önlüyo...
The Irish NewsCancer jabs destroy whole tumours in treatment-resistant cas...
AgenpressUno studio dimostra che un'iniezione contro il cancro può de...
S A N AMeme Kanseri Hastalarına Yeni Umut: Kemoterapi Yükü Azalabil...
Kent OnlineCancer jabs destroy whole tumours in treatment-resistant cas...
NTVMeme kanserinde çığır açan test. Milyonlarca hasta kemoterap...
EXPRESS'Cancer jab shrank my tongue cancer so I could eat steak aga...
Yeni ŞafakMeme kanserinde yeni DNA testiyle gereksiz kemoterapi tarihe...
AOL.comCancer jab can eradicate entire tumours in patients, trial s...
YahooNHS cancer jab eradicates tumours
BBCMeme kanserinde kemoterapi gerekmeyen hastalar için DNA test...
Haber Yazar | Güncel ve Son Dakika HaberlerMeme kanserinde gereksiz kemoterapi dönemini bitiren buluş: ...
TürkiyeKanser tedavisinde dönüm noktası! Hastaların büyük kısmı kem...
Yeni Akit Gazetesiİngiltere'de dikkat çeken araştırma: Milyonlarca meme kanser...
Ak�amYeni kanser tedavisi sayesinde milyonlarca kadın kemoterapid...
DünyaMeme kanserinde devrim niteliğinde gelişme - Dünya Gazetesi
HaberlerDNA testi ile gereksiz kemoterapi önlenecek
HuffPost ItaliaTest del Dna potrebbe evitare la chemioterapia a milioni di ...
Haber Yazar | Güncel ve Son Dakika HaberlerKanserde devrim niteliğinde adım: Artık her hastaya kemotera...
Haber Yazar | Güncel ve Son Dakika HaberlerMeme kanserinde yeni dönem: Kemoterapi devri kapanıyor mu?
Il MessaggeroTumore al seno, la svolta del test genetico. "Milioni di don...
bursahakimiyet.com.trMeme kanserinde kemoterapi dönemi kapanıyor mu? - Bursa Haki...
TRT haberMeme kanserinde kemoterapi dönemi kapanıyor mu?
T24Meme kanseri tedavisinde dönüm noktası: Milyonlarca kadın ke...
AgenpressUn test genomico potrebbe risparmiare la chemioterapia a mil...
https://www.pharmastar.itTumore del polmone non a piccole cellule resecabile, aggiunt...

A news briefing built to show both sides.

The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.

← Earlier in this briefing
European officials say Russia has stepped up efforts to obtain Western technolog...
Senior European intelligence officials told the Associated Press that Russia's intelligence services have intensified...
International Affairs

Continue Reading

Related this week

Canada pledges up to C$560 million to Brazilian-led tropical forest fund

Canada pledged up to C$560 million (US$392.5 million) over four years to the Brazilian-led Tropical Forests Forever...

Science & Climate
Related this week

Report: Mossad shared warning with CIA about possible Iranian drone attacks on Trump

Israel Hayom reported that Mossad shared intelligence with the CIA alleging that Iran could target President Donald...

International Affairs
From this briefing

Iran says it shot down a US MQ-1 drone over its territorial waters

Iran's Islamic Revolutionary Guard Corps said Sunday that it shot down a US military MQ-1 drone after it entered...

International Affairs
Back to all stories

A news briefing built to show both sides.

The day’s biggest stories in one short brief, built to show both sides and the competing values behind the headlines. Free in your inbox.

ReframedNews

A daily news briefing on the day’s top stories, built to show both sides.

Written by AI from news reporting. We review published briefings. Who writes this →

Navigate

Quick ReadArchiveSettings

Company

AboutHow it worksSkylark CreationsSign InTerms of ServicePrivacy Policy

© 2026 Reframed.News

Made by Skylark Creations